Evidence map›Paper›PMID 41039989›Full record

ArticleBiotechnology and bioengineering2026

Comprehensive Mapping of Functional Enhancers in Chinese Hamster Ovary Cells.

María Santos, Yusuf B Johari, Laura Biggins, Natalie C Elliott, Stefan Schoenfelder, Mounika Boddireddy, Daniel K Fabian, Michael Anbar, Peter M O'Callaghan, Peter J Rugg-Gunn

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

María SantosEpigenetics Programme, Babraham Institute, Cambridge, UK.ORCID 0000-0003-1740-7379
Yusuf B JohariLonza Biologics R&D, Cambridge, UK.ORCID 0000-0001-9933-5764
Laura BigginsBioinformatics Group, Babraham Institute, Cambridge, UK.ORCID 0000-0002-0975-1121
Natalie C ElliottLonza Biologics R&D, Cambridge, UK.
Stefan SchoenfelderEpigenetics Programme, Babraham Institute, Cambridge, UK.ORCID 0000-0002-3200-8133
Mounika BoddireddyLonza Biologics R&D, Cambridge, UK.
Daniel K FabianLonza Biologics R&D, Cambridge, UK.
Michael AnbarLonza Biologics R&D, Cambridge, UK.
Peter M O'CallaghanLonza Biologics R&D, Cambridge, UK.ORCID 0000-0003-4292-620X
Peter J Rugg-GunnEpigenetics Programme, Babraham Institute, Cambridge, UK.ORCID 0000-0002-9601-5949

Funding

This study was supported by funding from Lonza Biologics. Research in P.J.R.-G.'s laboratory is supported by grants from the BBSRC (BBS/E/B/000C0522; Core Capability Grant).
6 · The paper itself

Abstract

Chinese hamster ovary (CHO) cells are the leading mammalian system for recombinant therapeutic protein production. However, optimizing transgene expression remains challenging due to the limited understanding of the regulatory mechanisms controlling gene expression in CHO cells. Towards overcoming this barrier, here we provide a systematic characterization of cis-regulatory elements in CHO cells. Using genome-wide STARR-seq, a high-throughput method for quantifying enhancer strength, we identified regions with enhancer activity in the CHO cell genome. By integrating these data with ATAC-seq and histone modification profiles, we were able to characterize the chromatin state of these regions. Our analysis revealed thousands of newly identified enhancer sequences. The most active sequences could drive transgene expression at levels similar to or higher than strong viral enhancers. Notably, half of the regions found to have enhancer activity were within inaccessible chromatin in their native context. We observed that accessible enhancers were primarily near to transcriptional start sites and associated with ubiquitously-expressed genes, whereas inaccessible enhancers were predominantly intergenic and associated with tissue-specific genes. Additionally, through a deep-learning-based approach ETS and YY1 transcription factor (TF) binding motifs were identified as key determinants of enhancer identity and strength. Disrupting YY1 binding motifs led to reduced enhancer activity, thereby highlighting the importance of YY1 as a transcriptional activator in CHO cells. Our study demonstrates the first comprehensive map of functionally-validated enhancers in CHO cells and generates new insights into gene regulation and the role of TFs in determining enhancer strength. This study helps to lay the foundation for strategic engineering of CHO cell transcriptional networks to achieve enhanced biopharmaceutical production.

Indexed as

Chromosome MappingEnhancer Elements, GeneticAnimalsCHO CellsCricetinaeCricetulusCHO cellscis‐regulatory elementenhancergene regulationSTARR‐seqtranscription factor

Identifiers

PMID41039989
PMCPMC12699134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.